Dublin, Jan. 09, 2026 (GLOBE NEWSWIRE) -- The "Consumer Electronics Market by Product, Sales Channel, Countries and Companies Analysis 2025-2033" has been added to ResearchAndMarkets.com's offering.

The world has gone eight years, four months, and 11 days without a nuclear test — the longest streak ever, according to the Union of Concerned Scientists. Thomas Massie's joke about Epstein files in ...

Small businesses told Modern Retail they were shocked to find their products for sale on Amazon without their consent as part of a “Buy For Me” feature the retail giant announced in 2025. Some sellers ...

Sometime around Christmas, Sarah Burzio noticed that the holiday sales bump for her stationery business included some mysterious new customers: a flurry of orders from anonymous email addresses ...

She's not the only one boosting her Vinted sales with the trick either A VINTED seller has shared a genius hack to help boost your success on the site – without having to pay for it. Jess has turned ...

The recent termination of federal tax credits for zero-emission vehicles delivered a body blow to end-of-the-year sales across California. According to figures released Tuesday by the California ...

Performance data quoted represents past performance, which does not guarantee future results. Current performance may be lower or higher than the figures shown. Principal value and investment returns ...

Important Risks: The fund is actively managed and its characteristics will vary. Stock and bond values fluctuate in price so the value of your investment can go down depending on market conditions.

The news: Neuren Pharmaceuticals said it disclosed recent sales projections from its Rett syndrome treatment Daybue "promptly and without delay", in response to an ASX aware letter dated 15 January.

New research from a Boston College professor finds online retailers benefit by announcing low product availability Retailers can reduce the number of incidents where they run out of certain ...

Synaffix’s glycan-based antibody–drug conjugate technology is experiencing strong demand, based on its potential to improve safety and efficacy of cancer therapies without genetic engineering.